Identify inherited risks early, manage them better
call : +91 75691 32891
A high-quality laboratory follows internationally accepted standards such as the NCCN and ACMG guidelines to ensure gene selection, variant interpretation.
A reliable laboratory combines advanced technologies like next-generation sequencing (NGS) with robust validation processes to deliver highly accurate results.
A holistic patient care approach offering somatic and germline testing, advanced liquid biopsy for tumor profiling, pharmacogenomics, and preventive genomics. This integrated platform supports diagnosis, treatment selection, drug response, and long-term risk assessment for precise, personalized healthcare decisions.
Following ACMG guidelines, variants are classified as pathogenic, likely pathogenic, or VUS. Reports include therapy implications, prognostic insights, and risk assessment, presented in a concise, clinician-friendly format for quick, informed decision-making.
Fill out the form below to get instant access to the product brochure.